CD19 and chronic kidney disease: Our previous data and some other results showed that CD19(+)CD5(+) and CD19(+)CD5(−) B cells exhibited a significantly negative correlation with the progression of CKD in elderly patients and patients with decreased B cell counts had a higher risk of CVD mortality [13, 14].